Daniel J Wagner sold $294k of DGICA
Sr. VP & Treasurer at DONEGAL GROUP INC. 14,806 shares at an average of $19.87, traded May 7, 2025, filed May 9, 2025.
Score components
- +22RoleCFO
- +14Trade size$294k at market
- +20Share of holdings soldSold 63% of holdings
- +15Cluster14 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -1.2%, 3m -13.3%, 6m -0.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000800457-25-000067, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 7, 2025 | MOption exercise Class A Common Stock | +39 | $13.87 | $541 | 23,426 | May 9, 2025 |
| May 7, 2025 | MOption exercise Class A Common Stock | +77 | $14.09 | $1,085 | 23,503 | May 9, 2025 |
| May 7, 2025 | MOption exercise Class A Common Stock | +84 | $14.39 | $1,209 | 23,587 | May 9, 2025 |
| May 7, 2025 | SOpen-market sale Class A Common Stock | -200 | $20.00 | $4,000 | 23,387 | May 9, 2025 |
| May 8, 2025 | MOption exercise Class A Common Stock | +2,432 | $13.87 | $34k | 25,819 | May 9, 2025 |
| May 8, 2025 | MOption exercise Class A Common Stock | +4,863 | $14.09 | $69k | 30,682 | May 9, 2025 |
| May 8, 2025 | MOption exercise Class A Common Stock | +7,311 | $14.39 | $105k | 37,993 | May 9, 2025 |
| May 8, 2025 | SOpen-market sale Class A Common Stock | -14,606 | $19.87 | $290k | 23,387 | May 9, 2025 |
| May 7, 2025 | MOption exercise Optionsderivative | -39 | $13.87 | $541 | 16,769 | May 9, 2025 |
| May 7, 2025 | MOption exercise Optionsderivative | -77 | $14.09 | $1,085 | 15,539 | May 9, 2025 |
| May 7, 2025 | MOption exercise Optionsderivative | -84 | $14.39 | $1,209 | 14,341 | May 9, 2025 |
| May 8, 2025 | MOption exercise Optionsderivative | -2,432 | $13.87 | $34k | 14,337 | May 9, 2025 |
| May 8, 2025 | MOption exercise Optionsderivative | -4,863 | $14.09 | $69k | 10,676 | May 9, 2025 |
| May 8, 2025 | MOption exercise Optionsderivative | -7,311 | $14.39 | $105k | 7,030 | May 9, 2025 |
Related signals
Other insiders at DONEGAL GROUP INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 62Notable | DONEGAL GROUP INC | Kevin Gerard Burke President & Chief Exec Officer | $461k 24,000 shares | -63% | |
| 42Moderate | DGICAbuy DONEGAL GROUP INC | Donegal Mutual Insurance Co owner | $1.1M 54,725 shares | +0% | |
| 48Moderate | DONEGAL GROUP INC | Jeffrey Dean Miller EVP & Chief Financial Officer | $404k 21,000 shares | -44% | |
| 36Weak | DONEGAL GROUP INC | David Benjamin Bawel SVP & CHIEF ACCOUNTING OFFICER | $161k 8,326 shares | -27% | |
| 19Weak | DGICAbuy DONEGAL GROUP INC | Donegal Mutual Insurance Co owner | $449k 23,469 shares | +0% | |
| 16Weak | DGICAbuy DONEGAL GROUP INC | Donegal Mutual Insurance Co owner | $315k 16,368 shares | +0% | |
| 18Weak | DGICAbuy DONEGAL GROUP INC | Donegal Mutual Insurance Co owner | $382k 19,595 shares | +0% | |
| 29Weak | DONEGAL GROUP INC | Barry C Huber director | $87k 4,500 shares | -21% | |
| 46Moderate | DONEGAL GROUP INC | Vincent Anthony Viozzi Sr. VP & Chief Inv Officer | $44k 2,282 shares | -28% | |
| 17Weak | DGICAbuy DONEGAL GROUP INC | Donegal Mutual Insurance Co owner | $369k 19,257 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.